Oppenheimer analyst Francois Brisebois lowered the price target on Kala Pharmaceuticals (NASDAQ: KALA) to $13.00 (from $15.00) while maintaining an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE